CYC cyclopharm limited
Add to My Watchlist 0.88% ! 56.0¢

Ann: 40 Patient Milestone Achieved For Technegas USFDA Trial, page-3

  1. Eklavya
    368 Posts.
    lightbulb Created with Sketch.  5
    clock Created with Sketch.
    29/03/18
    09:43
    Post #: 32108329
    This has to be one of the small cap best biotech I came across in ASX. Meeting all the target on time, solid revenue base with significant upside potential, paying dividends. A bit more liquidity would have been better but other than that not sure what more can I ask for....
    CYC Price at posting: $1.19 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut
right-arrow Created with Sketch.
NEWS These 3 ASX stocks have quietly pulled back while most looked elsewhere
right-arrow Created with Sketch.
NEWS Money and Investing: We analysed 100 millionaires. Here are 10 habits that built real wealth
right-arrow Created with Sketch.
NEWS Tuesday's HotCopper trends: Telix Pharma, Larvotto, Evion Group, and other daily topics
right-arrow Created with Sketch.
NEWS Nowhere left to hide: cash strapped AI stocks' week of truth
right-arrow Created with Sketch.
NEWS View the latest ASX news here
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
56.0¢ 		Change
-0.005(0.88%) 		Mkt cap ! $71.22M
Open High Low Volume
56.5¢ 56.5¢ 56.0¢ 2.402K

Buyers (Bids)

Vol. Price($)
5660 53.0¢
 

Sellers (Offers)

Price($) Vol.
56.5¢ 4998
Last trade - 16.17pm 24/07/2026 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.